Further, ATF5 knockdown corrected the osteogenesis defect in m.3243A > G Mut-H USCs (Fig. 6F), suggesting this gene may serve as a potential therapeutic target for treatment of osteoporosis related to m.3243A > G mutation. This evidence concerns the gene ATF5 and osteoporosis.